跳至主要内容
临床试验/ACTRN12607000610437
ACTRN12607000610437已完成4 期

A randomized controlled trial of the effects of pioglitazone on bone density and bone turnover in type 2 diabetes mellitus

Andrew Grey0 个研究点目标入组 100 人开始时间: 2007年11月28日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
30 Years 至 o limit(—)
性别
All

入选标准

  • Type 2 diabetes mellitus (T2DM), as defined by fasting blood glucose > 7mmol/L and/or serum glucose > 11mmol/L 2h after ingesting 75g oral glucose.
  • - impaired glucose tolerance, as defined by fasting blood glucose < 6-7 mmol/L and/or serum glucose 7.8-11mmol/L 2h after ingesting 75g oral glucose

排除标准

  • Medical Conditions
  • - subjects with type 2 diabetes mellitus (T2DM) deemed to require early glitazone treatment and meeting Pharmac criteria for funded supply
  • - renal impairment (estimated glomerular filtration rate < 30ml/min).
  • - congestive heart failure, New York Heart Association Grade 2 or higher
  • - clinical liver disease.
  • - untreated thyroid dysfunction.
  • - concurrent major systemic illness, including malignancy.
  • - metabolic bone diseases, or serum alkaline phosphatase (ALP) > 2x normal limit.
  • - primary hyperparathyroidism.
  • - Bone mineral density (BMD) T score < -2.0 at total hip or spine
  • - previous fragility fracture (forearm, humerus, hip, vertebra)
  • - body weight >120kg
  • 2.2.2Medications
  • - use of oral glucocorticoid drugs equivalent to an average dose of prednisone = 2.5 mg/day in the preceding 12 months
  • - current or past use of bisphosphonate therapy
  • - use of hormone replacement therapy within the last 12 months
  • - use of other medication known to alter bone metabolism
  • - current use of thiazolidinediones
  • Insulin use is not an exclusion criterion, but insulin dose should be stable (+/- 20%) for 3 months before enrolment.

研究者

发起方
Andrew Grey

相似试验

已完成
不适用
A randomised controlled trial of the effect of a practice-based genetic screening facilitator.Genetic screening for haemoglobin disordersCirculatory SystemOther hereditary haemolytic anaemias
ISRCTN16886710Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
已完成
不适用
Enhancing parenting skills for women at risk of perinatal depression in a low-resource setting: a randomised controlled trial of Triple P for BabyPerinatal depression
ACTRN12621000073808The University of Queensland82
已完成
不适用
Is internet-delivered treatment specifically for symptoms of depression as effective as internet-delivered treatment for symptoms of both depression and anxiety, and are self-guided versions of these as effective as therapist-guided versions?Mental Health - DepressionDepression
ACTRN12612000421831Centre for Emotional Health, Department of Psychology, Macquarie University208
已完成
不适用
Is internet-delivered treatment specifically for symptoms of social phobia as effective as internet-delivered treatment for symptoms of both anxiety and depression, and are self-guided versions of these as effective as therapist-guided versions?Social phobiaMental Health - Anxiety
ACTRN12612000430831Centre for Emotional Health, Department of Psychology, Macquarie University208
已完成
不适用
Is internet-delivered treatment specifically for symptoms of panic disorder as effective as internet-delivered treatment for symptoms of both anxiety and depression, and are self-guided versions of these as effective as therapist-guided versions?Panic disorderMental Health - Anxiety
ACTRN12612000431820Centre for Emotional Health, Department of Psychology, Macquarie University208